Bearish
Our verdict — Barclays ranks #51 of 65 in our leaderboard: 59.4% hit rate across all stocks, 10.9% average gain per call, +3 pts vs its sector.
Inspire Medical Systems, Inc. (INSP) price target — analyst by analyst
Inspire Medical Systems, Inc. · Health Care · ref. ETF XLV · price $68.86
By Rédaction JPI Invest · updated
In short — 13 price targets published on Inspire Medical Systems, Inc. over 90 days: 5 bullish, 1 bearish (38% positive), median target $65. The highest-ranked firm to weigh in is Stifel (rank 18, 63% hit rate). For each call below we show the firm's real track record — not just its opinion.
The last 13 analyst calls on INSP
Newest first. The "verdict" is our read on the firm, based on its past calls replayed against actual prices.
Bullish
Freedom Capital Markets · Buy · target $97 (+39% vs price that day)
No verdict — this firm doesn't have enough scored calls for us to judge it reliably.
Neutral
Our verdict — RBC Capital ranks #62 of 65 in our leaderboard: 61% hit rate across all stocks, 9% average gain per call, -2 pts vs its sector.
Bullish
Freedom Capital Markets · Buy · target $97 (+28% vs price that day)
No verdict — this firm doesn't have enough scored calls for us to judge it reliably.
Bullish
Our verdict — Stifel ranks #18 of 65 in our leaderboard: 63% hit rate across all stocks, 22.2% average gain per call, +7 pts vs its sector.
Neutral
Our verdict — JP Morgan ranks #36 of 65 in our leaderboard: 63.1% hit rate across all stocks, 16% average gain per call, +4 pts vs its sector.
Bullish
Our verdict — Mizuho ranks #30 of 65 in our leaderboard: 61.1% hit rate across all stocks, 20.2% average gain per call, +5 pts vs its sector.
Bullish
Our verdict — Oppenheimer ranks #29 of 65 in our leaderboard: 66.3% hit rate across all stocks, 20.5% average gain per call, +5 pts vs its sector.
Neutral
Our verdict — Truist Securities ranks #50 of 65 in our leaderboard: 63.7% hit rate across all stocks, 14.8% average gain per call, +3 pts vs its sector.
Neutral
Our verdict — Evercore ISI Group ranks #41 of 65 in our leaderboard: 62.2% hit rate across all stocks, 15.2% average gain per call, +4 pts vs its sector.
Neutral
Our verdict — Piper Sandler ranks #26 of 65 in our leaderboard: 62% hit rate across all stocks, 19.9% average gain per call, +5 pts vs its sector.
Neutral
Our verdict — Baird ranks #52 of 65 in our leaderboard: 64.2% hit rate across all stocks, 16.7% average gain per call, +2 pts vs its sector.
Neutral
Our verdict — Truist Securities ranks #50 of 65 in our leaderboard: 63.7% hit rate across all stocks, 14.8% average gain per call, +3 pts vs its sector.
⚠️ Price targets as published by the firms, timestamped at their publication date. The upside shown is vs the price on the day of the call, not today's price. Informational data, not investment advice.
Frequently asked questions
What are analysts saying about INSP right now?
Over the last 90 days, 13 price targets were published on Inspire Medical Systems, Inc.: 5 bullish and 1 bearish (38% positive). The median target is $65. The latest call is from October 7, 2026.
Should you trust these price targets?
Not blindly — that's the point of this page: next to each call we show the firm's real track record — its rank among 65 tracked firms, its hit rate and its average gain per call. An ambitious target from a firm that is wrong 6 times out of 10 is not worth the same as one from a consistent firm.
Which firm covering INSP is the most reliable?
Among the firms that published on Inspire Medical Systems, Inc. in the last 90 days, our highest-ranked is Stifel (rank 18 of 65, 63% hit rate, 22.2% average gain per call).
Where does this data come from?
From analyst price targets, timestamped at publication then replayed against the actual price. Firm rankings come from our analyst leaderboard. Updated daily.
💬 A question about Inspire Medical Systems, Inc.? The JPI assistant answers using our backtest data.
Keep exploring Inspire Medical Systems, Inc.